world
shock
earli
pandem
sever
acut
respiratori
syndrom
sar
immin
outbreak
novel
diseas
caus
novel
coronaviru
sarscoronaviru
hit
hardest
asian
pacif
region
though
eventu
spread
five
contin
speed
spread
sar
epidem
unpreced
due
highli
effici
intercontinent
transport
intern
collabor
effort
world
health
organ
help
identifi
aetiolog
agent
month
onset
epidem
power
molecular
biolog
bioinformat
enabl
complet
decod
viral
genom
within
week
public
phylogeni
epidemiolog
genom
laboratori
diagnost
antivir
immun
pathogenesi
clinic
diseas
manag
accumul
within
year
although
exact
anim
reservoir
viru
evolv
human
pathogen
still
obscur
accur
diagnosi
epidemiolog
control
diseas
possibl
articl
review
current
known
viru
diseas
journal
neurovirolog
keyword
coronaviru
patholog
sar
sever
acut
respiratori
syndrom
vaccin
virolog
epidemiolog
sever
acut
respiratori
syndrom
sar
first
pandem
new
millennium
caus
hitherto
unknown
viru
diseas
manifest
primarili
acut
communityor
hospitalacquir
pneumonia
respond
antimicrobi
coverag
typic
atyp
pathogen
end
first
wave
outbreak
case
death
occur
five
contin
world
health
organ
humantohuman
transmiss
occur
hospit
clinic
hotel
workplac
home
taxi
airplan
world
health
organ
initi
pandem
end
june
four
outbreak
occur
septemb
may
three
four
instanc
associ
like
associ
laboratoryacquir
infect
orellana
lim
et
al
laboratoryacquir
case
singapor
taiwan
limit
one
affect
personnel
wherea
latest
instanc
beij
associ
secondari
tertiari
case
world
health
organ
virusnow
name
sarscoronaviru
sarscov
probabl
circul
among
wild
mammal
subsequ
transmit
human
viru
probabl
origin
wild
game
food
anim
cage
wet
market
southern
china
palm
civet
like
amplif
host
one
like
candid
introductori
host
first
case
pandem
guangdong
outbreak
histori
eat
occup
contact
wild
game
anim
howev
import
rout
transmiss
appear
direct
indirect
contact
infecti
respiratori
droplet
fomit
mucou
membran
eye
mouth
nose
world
health
organ
respiratori
droplet
transmiss
health
care
worker
might
augment
nebul
use
sar
patient
varia
et
al
world
health
organ
addit
airborn
transmiss
health
care
worker
suspect
manipul
patient
airway
suction
intub
bronchoscopi
cardiopulmonari
resuscit
christian
et
al
sever
acut
respiratori
syndrom
sar
ssi
wong
ky
yuen
common
sourc
outbreak
hous
complex
hong
kong
also
suggest
airborn
transmiss
may
occur
previous
unreport
fashion
virusladen
aerosol
gener
toilet
flush
may
suck
back
sewag
drain
dri
u
trap
toilet
result
strong
neg
pressur
gener
exhaust
fan
plume
contamin
warm
air
ascend
light
well
floor
carri
wind
block
hous
complex
cultiv
virus
could
found
stool
quantit
revers
transcriptasepolymeras
chain
reaction
rtpcr
show
high
viral
load
peiri
et
al
suggest
fecoor
transmiss
could
anoth
possibl
mode
transmiss
food
water
vector
pestborn
transmiss
could
document
despit
hypothesi
rat
may
altern
explan
outbreak
hous
complex
ng
incub
period
estim
day
world
health
organ
epidemiolog
control
measur
base
world
health
organizationrecommend
maxim
incub
period
day
found
effect
interrupt
transmiss
overal
averag
number
secondari
case
result
singl
case
two
four
world
health
organ
asymptomat
mildli
symptomat
infect
appear
associ
transmiss
posit
viral
cultur
seroepidemiolog
studi
show
highli
variabl
seropreval
normal
individu
health
care
worker
ca
asymptomat
famili
contact
quarantin
depend
type
serolog
assay
use
cohort
popul
lee
et
al
peiri
et
al
woo
et
al
zheng
et
al
transmiss
symptomat
patient
tend
occur
fifth
day
later
onset
symptom
especi
sever
ill
patient
afebril
day
transmiss
could
document
although
initi
case
outbreak
retrospect
identifi
novemb
decemb
respect
definit
season
diseas
demonstr
thu
far
result
intens
success
intervent
pandem
mysteri
surround
new
diseas
two
epidemiolog
question
particularli
intrigu
first
pertain
natur
reservoir
sarscov
transmiss
dynam
amplif
recombin
game
anim
cage
market
lead
interspeci
jump
import
prevent
transmiss
similar
diseas
anim
human
unsolv
issu
socal
superspread
event
sar
patient
led
disproportion
larg
number
transmiss
understand
viral
multipl
infecti
droplet
format
social
behavior
host
anoth
import
area
research
sarscov
envelop
positivesens
singlestrand
rna
viru
identifi
independ
three
laboratori
differ
contin
almost
time
peiri
et
al
drosten
et
al
ksiazek
et
al
primari
viral
isol
success
embryon
monkey
cell
line
includ
vero
cell
subcultur
onto
vero
cell
liver
cancer
cell
line
simmon
et
al
colon
carcinoma
cell
line
call
mink
lung
epitheli
cell
also
permiss
growth
sarscov
unlik
human
coronavirus
viru
prolifer
rapidli
caus
obviou
cytopathet
effect
vero
within
h
inocul
compar
human
coronavirus
sarscov
appear
higher
degre
stabil
environ
rabenau
et
al
case
human
coronavirus
sarscov
capabl
infect
human
rat
neural
cell
line
though
much
lower
level
viral
product
cyopath
effect
observ
yamashita
et
al
dri
surfac
room
temperatur
sarscov
could
surviv
least
day
wherea
stool
sampl
surviv
day
expect
tabl
resist
heat
chemic
disinfect
similar
envelop
virus
appear
electron
microscopi
genom
order
replicasestructur
spikeenvelopemembranenucleocapsid
complet
genom
sequenc
characterist
coronavirida
known
coronavirus
coronaviru
affect
human
seem
phylogenet
distinct
three
group
shown
distantli
relat
group
ii
virus
current
classifi
group
iib
human
coronavirus
belong
antigen
group
van
der
hoek
et
al
fouchier
et
al
wherea
human
coronaviru
newli
describ
belong
group
iia
group
iii
contain
avian
coronavirus
use
rel
rapid
mutat
surfac
spike
protein
phylogenet
marker
analysi
sarscov
isol
hong
kong
outbreak
show
sever
introduct
occur
one
associ
major
outbreak
hong
kong
rest
world
strain
found
begin
outbreak
phylogenet
distinct
major
cluster
closer
guangdong
beij
strain
concur
epidemiolog
studi
identifi
index
patient
hong
kong
outbreak
guangzhou
medic
holm
sizun
et
al
yeager
et
al
b
refer
inform
van
der
hoek
et
al
c
refer
inform
arbour
et
al
arbour
et
al
holm
krempl
et
al
kunkel
et
al
mounir
et
al
sizun
et
al
zhang
et
al
refer
inform
woo
et
al
e
refer
inform
sarscov
li
et
al
peiri
et
al
peiri
et
al
rota
et
al
world
health
organ
yao
et
al
doctor
travel
hong
kong
similar
molecular
epidemiolog
studi
outbreak
guangdong
also
suggest
diseas
appear
spread
guangdong
hong
kong
rest
world
index
case
chef
handl
game
food
anim
subsequ
anim
surveil
recov
strain
coronaviru
nucleotid
homolog
human
viru
characterist
insert
open
read
frame
orf
also
name
found
anim
isol
snijder
et
al
segment
delet
transmiss
human
cross
speci
human
biolog
effect
delet
worth
research
howev
number
human
virus
later
stage
sar
epidem
larger
delet
around
site
chines
sar
molecular
epidemiolog
consortium
significantli
higher
seropreval
sarscov
antibodi
found
wild
anim
trader
slaughter
also
support
viru
jump
anim
human
inde
two
independ
molecular
epidemiolog
studi
complet
genom
comparison
viru
isol
found
evid
strong
posit
select
begin
epidem
follow
purifi
select
indic
amino
acid
substitut
rate
spike
yeh
et
al
chines
sar
molecular
epidemiolog
consortium
studi
suggest
find
sever
acut
respiratori
syndrom
sar
compat
molecular
adapt
viru
jump
anim
human
small
outbreak
guangzhou
four
human
isol
belong
separ
sublineag
concurr
anim
predominantli
civet
cat
isol
distinct
human
pandem
anim
viru
though
sarscov
rather
distinct
three
exist
group
coronavirus
may
closer
group
ii
cystein
found
domain
spike
protein
spatial
conserv
compar
group
ii
consensu
sequenc
wherea
cystein
residu
conserv
compar
group
ii
coronavirus
believ
coevolut
anim
host
suggest
rat
mice
cattl
harbor
group
ii
coronavirus
like
anim
host
sarscov
cat
harbor
group
coronaviru
howev
comparison
phylogenet
tree
known
hostspeci
nucleocapsid
sequenc
coronavirus
done
use
interfer
approach
slide
window
analysi
statist
incongru
indic
multipl
hostspeci
shift
coronavirus
mani
anim
phylogenet
distant
rest
mindel
thu
even
civet
cat
relat
mammal
true
anim
reservoir
rather
mice
rat
would
big
surpris
moreov
civet
cat
relat
mammal
least
serv
major
amplif
mechan
market
southern
china
irrespect
origin
anim
reservoir
control
anim
market
play
pivot
role
epidemiolog
control
sar
besid
molecular
epidemiolog
genom
sequenc
provid
invalu
inform
pathogenesi
target
diagnost
immun
antivir
therapi
metalloproteas
angiotensinconvert
enzym
vero
cell
found
bind
domain
spike
protein
viru
li
et
al
cell
transfect
form
multinucl
syncytia
cell
express
spike
express
present
enterocyt
pneumocyt
vascular
endotheli
smooth
muscl
cell
ham
et
al
leung
et
al
consist
clinic
histopatholog
manifest
sar
includ
diffus
alveolar
damag
colon
mucos
presenc
abund
viral
particl
patient
diarrhoea
pulmonari
vascul
thrombosi
shown
crucial
cellular
receptor
sarscov
vivo
lack
viru
infect
cell
line
express
led
search
altern
cellular
receptor
one
candid
receptor
call
dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrinrel
dcsignr
type
ii
ctype
lectin
receptor
also
known
lsign
jeffer
et
al
signific
altern
receptor
still
await
confirm
fragment
contain
amino
acid
domain
local
minim
receptorbind
region
found
truncat
bind
assay
babcock
et
al
rather
si
helicas
proteinas
clone
character
anand
et
al
chou
et
al
tanner
et
al
yang
et
al
molecular
model
rnadepend
rna
polymeras
also
publish
provid
clue
function
aspect
enzym
therefor
may
facilit
design
new
antivir
futur
put
target
nonstructur
protein
put
mrna
methyltransferas
investig
intens
bioinformat
crystal
structur
studi
campanacci
et
al
egloff
et
al
von
grotthuss
et
al
fulllength
cdna
viral
genom
shown
caus
lytic
infect
cell
line
good
viral
titr
antigen
express
yount
et
al
would
provid
tool
studi
function
mani
nonstructur
protein
revers
genet
sar
gener
manifest
viral
pneumonia
rapid
respiratori
deterior
two
third
affect
individu
world
health
organ
affect
age
group
slight
bia
femal
preliminari
genet
suscept
studi
suggest
associ
hlab
sever
sar
perhap
suscept
infect
chines
popul
studi
involv
chines
popul
hong
kong
associ
suscept
resist
sar
found
hlab
ci
respect
coinherit
b
significantli
higher
patient
sar
gener
popul
associ
hlab
found
diseas
sever
later
studi
patient
typic
present
fever
chill
myalgia
malais
nonproduct
cough
upper
respiratori
tract
symptom
runni
nose
sore
throat
less
promin
patient
usual
admit
persist
fever
worsen
cough
short
breath
deterior
especi
promin
week
onset
symptom
often
coincid
appear
wateri
diarrhoea
physic
find
chest
examin
disproport
mild
compar
chang
chest
radiographi
radiograph
abnorm
includ
ground
glass
opac
focal
consolid
expect
histolog
find
interstiti
pneumonia
alveolar
exud
lung
biopsi
postmortem
examin
earli
stage
sar
chang
typic
found
peripher
often
subpleur
region
lower
zone
initi
chest
radiograph
diseas
progress
extens
involv
lung
occur
late
characterist
radiolog
chang
includ
shift
radiograph
shadow
pneumomediastinum
without
preced
posit
pressur
ventil
far
commonest
extrapulmonari
manifest
diarrhoea
follow
hepat
dysfunct
chau
et
al
dizzi
may
relat
diastol
cardiac
impair
li
et
al
abnorm
urinalysi
petechi
skin
rash
wu
sung
myositi
wang
et
al
epilept
fit
elderli
patient
sar
may
present
fall
fractur
lead
socal
afebril
hidden
sar
chow
et
al
viral
replic
differ
site
appar
import
pathogenesi
clinic
laboratori
abnorm
sar
serum
viral
load
associ
oxygen
desatur
mechan
ventil
mortal
stool
viral
load
associ
diarrhoea
urin
viral
load
abnorm
urinalysi
peripher
blood
examin
often
reveal
iymphocytopenia
sometim
thrombocytopenia
increas
ddimer
activ
partial
thromboplastin
time
hepat
parenchym
enzym
muscl
enzym
lactat
dehydrogenas
may
increas
patient
continu
deterior
requir
mechan
ventil
intens
care
unit
overal
mortal
mainli
relat
uncontrol
respiratori
failur
sepsi
precipit
underli
medic
ill
poor
prognost
factor
includ
age
comorbid
heart
diseas
diabet
mellitu
increas
lactat
dehydrogenas
level
high
neutrophil
count
time
admiss
recov
sar
residu
ground
glass
opacif
follow
chest
radiograph
probabl
relat
fibrosi
case
restrict
lung
function
test
abnorm
attribut
residu
lung
fibrosi
muscl
weak
depress
posttraumat
stress
disord
especi
common
patient
affect
famili
member
health
care
worker
biochem
evid
adren
insuffici
magnet
reson
imag
mri
evid
avascular
bone
necrosi
also
note
patient
treat
corticosteroid
sar
clinic
distinguish
caus
acut
pneumonia
initi
stage
case
initi
defin
clinic
epidemiolog
criteria
later
confirm
virolog
test
besid
posit
viral
cultur
respiratori
fecal
occasion
urin
specimen
fourfold
rise
neutral
antibodi
titr
serum
taken
admiss
day
afterward
remain
gold
standard
confirm
diagnosi
viral
cultur
insensit
neutral
antibodi
test
difficult
offer
retrospect
confirm
clinic
manag
realtim
quantit
rtpcr
modifi
rna
extract
protocol
abl
achiev
sensit
good
specif
nasopharyng
specimen
collect
within
first
day
ill
serum
specimen
test
fecal
specimen
especi
use
first
week
ill
recent
studi
show
quantit
revers
transcriptionpolymeras
chain
reaction
higher
sensit
polyclon
monoclon
antibodybas
nucleocapsid
antigen
captur
enzymelink
immunosorb
assay
fecal
urin
sampl
initi
posit
rtpcr
result
must
confirm
test
second
clinic
specimen
reextract
test
origin
specimen
repeat
rtpcr
target
differ
part
genom
conserv
gener
polymeras
gene
conserv
wherea
nucleocapsid
gene
highest
copi
number
infect
cell
due
uniqu
transcript
strategi
coronaviru
subgenom
rna
format
confirm
sar
case
may
persist
posit
rtpcr
daysparticularli
stool
specimensbut
viru
cultur
day
onset
symptom
view
hazard
associ
perform
neutral
antibodi
test
laboratori
opt
indirect
immunofluoresc
antibodi
test
use
inactiv
whole
virusinfect
cell
line
recombin
nucleocapsid
enzym
immunoassay
eia
use
rapid
screen
test
result
confirm
neutral
antibodi
indirect
immunofluoresc
antibodi
test
convalesc
sera
patient
infect
human
coronaviru
may
crossreact
recombin
nucleocapsid
eia
rare
even
indirect
immunofluoresc
test
viral
load
studi
differ
clinic
specimen
show
viral
load
nasopharyng
specimen
serum
even
admiss
highli
correl
respiratori
failur
mortal
similarli
viral
load
stool
urin
day
onset
symptom
correl
presenc
diarrhea
abnorm
urinalysi
respect
longitudin
studi
nasopharyng
aspir
sar
patient
show
viral
load
peak
around
day
onset
symptom
peiri
et
al
viral
load
decreas
irrespect
clinic
deterior
improv
viral
load
profil
distinct
influenza
respiratori
syncyti
viru
viral
load
peak
first
day
onset
symptom
three
laboratori
outbreak
sar
hasten
use
pseudotyp
virus
research
neutral
antibodi
test
studi
use
pseudotyp
retrovir
vector
carri
e
protein
show
protein
necessari
suffici
viru
attach
suscept
cell
simmon
et
al
viru
entri
occur
via
phdepend
receptormedi
endocyt
pathway
pseudotyp
viru
carri
protein
bind
dcsign
dendrit
cell
without
caus
cell
death
replic
dendrit
cell
may
serv
conduit
infect
suscept
host
cell
case
hiv
acut
diffus
alveolar
damag
air
space
edema
promin
featur
patient
die
tenth
day
onset
ill
nichol
et
al
frank
et
al
addit
hyalin
membran
interstiti
oedema
interstiti
infiltr
inflammatori
cell
bronchiolar
injuri
loss
cilia
bronchiol
epitheli
denud
focal
deposit
fibrin
expos
basement
membran
also
note
patient
die
day
ill
exhibit
mixtur
acut
chang
organ
phase
diffus
alveolar
damag
interstiti
airspac
fibroblast
prolifer
type
ii
pneumocyt
hyperplasia
squamou
metaplasia
bronchial
epithelium
alveolar
space
contain
combin
macrophag
desquam
pneumocyt
multinucl
cell
hemophagocytosi
alveolar
exud
thrombosi
venul
note
case
pulmonari
chang
includ
secondari
bacteri
bronchopneumonia
invas
aspergillosi
wang
et
al
system
vascul
involv
wall
small
vein
edema
fibrinoid
necrosi
infiltr
monocyt
lymphocyt
plasma
cell
note
one
report
tissu
destruct
inflammatori
process
associ
viral
infect
note
organ
tissu
viru
detect
situ
hybrid
pneumocyt
enterocyt
small
intestin
howev
remark
histolog
chang
found
intestin
mucosa
account
wateri
diarrhea
immunohistochem
stain
show
presenc
viral
protein
pneumocyt
occasion
macrophag
anoth
common
extrapulmonari
patholog
presenc
necrosi
atrophi
lymphoid
tissu
lymph
node
white
pulp
spleen
peripher
blood
examin
flow
cytometri
time
admiss
use
steroid
shown
decreas
level
dendrit
cell
subset
natur
killer
cell
lymphocyt
b
lymphocyt
cui
et
al
li
et
al
zhang
et
al
studi
three
sar
patient
suggest
selflimit
abort
infect
peripher
blood
mononuclear
cell
occur
evid
presenc
minusrna
replic
intermedi
viru
initi
week
ill
li
et
al
studi
cytokin
profil
sar
patient
show
signific
elev
plasma
chemokin
interleukin
il
monocyt
chemoattact
protein
mcp
induc
relat
cytokin
interferon
ifn
inflammatori
cytokin
induc
intens
inflammatori
respons
jone
et
al
may
account
recruit
accumul
alveolar
macrophag
polymorph
activ
thl
cellmedi
immun
stimul
natur
killer
cytotox
lymphocyt
gener
specif
serum
antibodi
indirect
immunofluoresc
neutral
test
start
appear
around
day
plateau
around
second
month
maintain
month
immunoglobulin
igm
igg
appear
around
time
former
detect
month
serum
test
recombin
nucleocapsid
eia
detect
antibodi
earli
fifth
day
onset
symptom
rise
antibodi
titr
coincid
reduct
viral
load
continu
deterior
one
third
case
research
dilig
search
marker
immunopatholog
autoantibodi
antiphospholipid
antibodi
chemokin
cytokin
marker
patholog
clinic
manifest
sar
like
repres
mixtur
direct
cellular
invas
destruct
sarscov
immunolopatholog
damag
result
infect
interact
differ
viral
compon
host
molecul
shown
facilit
viral
invas
promot
inflammatori
respons
exampl
includ
liver
lymph
node
sinusoid
endotheli
cell
ctype
lectin
lsectin
coexpress
dcsignr
hepat
lymph
node
sinusoid
endotheli
cell
may
augment
infect
sarscov
tissu
gramberg
et
al
antibodi
domain
sarscov
spike
protein
act
autoantibodi
induc
cellular
cytotox
human
lung
adenocarcinoma
cell
line
may
partli
account
lung
injuri
seen
sar
infect
lin
et
al
although
sarscov
caus
nonpermiss
infect
human
macrophag
dendrit
cell
physiolog
immunolog
modul
immun
cell
still
demonstr
could
result
enhanc
proinflammatori
respons
tseng
et
al
addit
crucial
cellular
receptor
sarscov
interact
may
also
play
key
role
genesi
acut
respiratori
distress
syndrom
ard
sarscov
infect
viral
spike
protein
downregul
express
sinc
protect
develop
ard
mice
model
depress
may
therefor
detriment
effect
pulmonari
injuri
seen
sar
role
ace
gene
polymorph
sar
without
ard
investig
sever
acut
respiratori
syndrom
sar
ssi
wong
ky
yuen
hong
kong
vietnam
studi
fail
show
signific
associ
itoyama
et
al
although
anoth
studi
show
polymorph
could
associ
develop
hypoxemia
sar
patient
itoyama
et
al
polymorph
two
interferoninduc
gene
oligoadenyl
synthetas
myxoviru
resistancea
also
suggest
affect
diseas
progress
hamano
et
al
despit
consist
isol
sarscov
without
known
respiratori
pathogen
sar
patient
subsequ
seroconvers
viru
differ
contin
caus
role
viru
challeng
chlamydia
human
metapneumoviru
issu
final
settl
primat
model
infect
demonstr
viral
excret
diffus
alveolar
damag
subsequ
seroconvers
cynomolgu
macaqu
macaca
fasciculari
inocul
sarscov
inocul
monkey
human
metapneumoviru
alon
reproduc
patholog
aggrav
diseas
two
viru
inocul
togeth
later
serolog
virolog
surveil
market
southern
china
found
chines
ferret
badger
melogal
moschata
mask
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
infect
anoth
lineag
sarscov
investig
outbreak
hong
kong
hous
complex
also
found
domest
cat
infect
preval
sarscov
therefor
ferret
mustela
furo
domest
cat
feli
domesticu
experiment
inocul
shown
suscept
infect
sarscov
martina
et
al
cat
asymptomat
infect
ferret
die
infect
furthermor
asymptomat
infect
associ
viral
replic
lung
nasal
turbin
balbc
mice
also
establish
intranas
inocul
golden
syrian
hamster
also
suscept
sarscov
infect
high
level
viral
replic
respiratori
tract
without
develop
clinic
diseas
robert
et
al
therefor
suitabl
altern
anim
model
studi
sarscov
recent
common
marmoset
callithrix
jacchu
found
anoth
nonhuman
primat
model
develop
pneumon
multiorgan
infect
follow
sarscov
infect
greenough
et
al
distantli
relat
carnivor
infect
viru
anim
reservoir
pathogen
may
broader
initi
expect
rapid
develop
anim
model
import
implic
understand
pathogenesi
sar
test
put
antivir
vaccin
absenc
data
random
placebo
control
trial
antivir
immunomodul
sar
respiratori
support
intens
care
remain
cornerston
clinic
manag
oxygen
deliveri
lowflow
nasal
cannula
rather
highflow
face
mask
use
reduc
risk
cross
infect
aerosol
infecti
respiratori
secret
mode
noninvas
ventil
continu
posit
airway
pressur
cpap
bilevel
posit
airway
pressur
bipap
perform
neg
pressur
isol
room
adequ
person
protect
equip
health
care
worker
lowtidalvolum
strategi
lung
protect
use
requir
mechan
ventil
broadspectrum
antibacteri
therapi
often
administ
coverag
acut
communityacquir
typic
atyp
pneumon
agent
first
week
ill
avail
virolog
confirm
dilig
search
hospitalacquir
sepsi
perform
patient
put
ventil
especi
given
corticosteroid
presenc
viral
particl
diseas
lung
strong
associ
initi
peak
viral
load
mortal
suggest
effect
antivir
reduc
peak
viral
load
may
key
object
treatment
sar
may
decreas
cytolyt
damag
degre
inflammatori
immunodysregulatori
damag
excit
viral
infect
result
decreas
viral
burden
report
find
vitro
suscept
test
conflict
may
reflect
use
differ
assay
condit
endpoint
determin
contradictori
result
report
interferon
cinatl
et
al
hensley
et
al
tan
et
al
interferon
tan
et
al
stroher
et
al
report
note
suscept
toward
ribavirin
concentr
mgl
relat
cellular
toxic
tan
et
al
wherea
anoth
report
cytotox
concentr
ribavirin
exce
mgl
vero
cell
cinatl
et
al
howev
much
lower
inhibitori
concentr
clinic
achiev
demonstr
cell
line
includ
hpek
furthermor
synergist
activ
ribavirin
also
shown
studi
overal
appear
interferon
interferon
interferon
leukocyt
interferon
activ
consid
clinic
trial
mani
new
compound
especi
proteas
inhibitor
xiong
et
al
analogu
towler
et
al
helicas
inhibitor
nucleosid
analogu
screen
combinatori
chemic
librari
report
possess
good
vitro
antisarscov
activ
combin
interferon
compound
ribavirin
synergist
mortal
sar
china
tradit
chines
herbal
medicin
use
treatment
appear
lower
purifi
compound
extract
herb
also
test
glycyrrhizin
baicalin
appear
activ
effect
concentr
glycyrrhizin
unlik
clinic
achiev
cinatl
et
al
antivir
peptid
design
glue
claw
mechan
spike
protein
use
cell
entri
appear
use
vitro
kliger
levanon
liu
et
al
similarli
sirna
design
sequenc
specif
degrad
viral
rna
gener
transcript
also
appear
use
zhang
et
al
due
lack
clinic
effect
antivir
mani
clinician
resort
empir
use
immunodul
includ
corticosteroid
intraven
immunoglobulin
pentaglobin
thymosin
thalidomid
antitumor
necrosi
factor
pandem
use
corticosteroid
viral
pneumonia
due
varicellazost
viru
influenza
viru
virus
report
case
seri
english
literatur
greav
et
al
ahm
et
al
mortal
first
two
condit
appear
lower
corticosteroid
support
treatment
alon
howev
absenc
effect
antivir
earli
use
high
dose
corticosteroid
prolong
period
probabl
counterproduct
may
increas
risk
hospitalacquir
sepsi
avasuclar
bone
necrosi
auyeung
et
al
pegyl
interferon
shown
use
prophylaxi
decreas
respiratori
viral
shed
lung
patholog
use
earli
treatment
monkey
model
haagman
et
al
combin
steroid
either
recombin
consensu
loutfi
et
al
lopinavirritonavir
ribavirin
shown
improv
outcom
two
differ
treatment
trial
use
histor
control
use
passiv
immun
convalesc
plasma
contain
high
titer
neutral
antibodi
demonstr
treatment
lassa
fever
similar
treatment
tri
empir
deterior
sar
case
later
stage
appear
benefici
howev
obviou
side
effect
observ
moment
hyperimmun
globulin
manufactur
convalesc
patient
plasma
hors
immun
inactiv
sarscov
avail
prophylact
trial
human
anoth
potenti
candid
human
monoclon
iggl
produc
singlechain
variabl
region
fragment
domain
two
nonimmun
human
antibodi
librari
sui
et
al
strong
neutral
activ
compar
bind
affin
spike
solubl
mous
model
asymptomat
sar
infect
passiv
transfer
immun
serum
contain
high
titer
neutral
antibodi
prevent
viru
replic
lung
effect
nasal
turbin
use
mice
model
plasmid
dna
vaccin
carri
spike
protein
encod
human
codon
shown
highli
protect
challeng
sarscov
moreov
tcell
deplet
specif
monoclon
antibodi
alon
combin
affect
protect
immun
confirm
adopt
tcell
transfer
donor
lymphocyt
alon
inhibit
pulmonari
viral
replic
recipi
mice
wherea
passiv
transfer
purifi
igg
immun
mice
achiev
similar
protect
junctur
appear
humor
immun
respons
viral
spike
antigen
key
factor
protect
primari
infect
immunolog
navi
host
similar
find
found
mous
model
use
either
intramuscular
intranas
administr
highli
attenu
modifi
vaccinia
viru
ankara
carri
spike
protein
bisht
et
al
approach
use
adenovir
vector
encod
domain
membran
nucleoprotein
dna
vaccin
link
nucleocapsid
protein
calreticulin
shown
induc
viru
specif
immun
test
anim
model
kim
et
al
still
uncertain
rel
import
system
mucos
immun
term
neutral
antibodi
cytotox
tlymphocyt
respons
spike
nucleocapsid
target
term
recoveri
sar
neutral
antibodi
spike
appear
import
prophylact
immun
use
liveattenu
viru
question
concern
revers
virul
recombin
wild
strain
form
new
wild
type
readili
avail
vaccin
undergo
clinic
trial
inactiv
sarscov
howev
laboratori
safeti
major
safeti
issu
cultiv
huge
stock
viru
recombin
protein
express
mammalian
cell
altern
induct
good
neutral
antibodi
respons
nonrepl
coronaviru
particl
safe
close
mimic
live
viru
term
imunogen
irrespect
approach
use
immun
import
note
immun
enhanc
diseas
occur
felin
periton
coronaviru
infect
atyp
sever
diseas
occur
use
inactiv
measl
respiratori
syncyti
viru
vaccin
ferret
model
immun
modifi
vaccinia
viru
ankarabas
recombin
vaccin
immun
anim
develop
sever
hepat
follow
sarscov
challeng
weingartl
et
al
futur
vaccin
studi
must
take
account
potenti
advers
effect
go
clinic
trial
moreov
econom
viabil
sar
vaccin
depend
whether
sar
come
back
whether
major
antigen
variat
affect
effect
vaccin
possibl
use
farm
set
wild
game
food
anim
may
worth
investig
stabil
sarscov
environ
absenc
protect
immun
gener
popul
lack
effect
antivir
vaccin
demand
nearperfect
complianc
health
care
laboratori
worker
infect
control
measur
health
care
set
triag
earli
case
detect
isol
suspect
case
nosocomi
transmiss
key
issu
respiratori
droplet
contact
precaut
shown
effect
prevent
nosocomi
transmiss
diseas
circumst
addit
measur
airborn
precaut
necessari
situat
droplet
nuclei
like
gener
strict
hand
hygien
patrol
nurs
overse
gown
degown
procedur
sar
ward
appear
critic
prevent
hospit
transmiss
commun
set
contact
trace
quarantin
contact
prevent
commun
spread
temperatur
check
border
health
declar
travel
public
educ
effect
risk
commun
public
media
proven
effect
control
outbreak
sar
laboratori
handl
sar
specimen
must
compli
world
health
organ
standard
accur
log
secur
storag
viru
infect
sampl
import
avoid
accid
amount
store
clinic
specimen
must
kept
level
suffici
research
purpos
institut
live
viru
cultiv
manipul
laboratori
must
regularli
audit
meet
safeti
standard
biosafeti
level
laboratori
daili
check
temperatur
report
sick
part
monitor
protocol
laboratori
worker
handl
live
virus
cultur
open
mistak
nonwitchhunt
attitud
investig
incid
overse
thu
complianc
built
team
member
afraid
punish
admiss
accid
laps
densiti
human
domest
wild
food
anim
southern
china
make
ideal
incub
emerg
infect
novel
infect
usual
limit
epidem
potenti
among
human
initi
cross
speci
barrier
howev
accumul
appropri
genet
chang
may
acquir
abil
transmit
effici
human
human
infect
influenza
virus
exampl
former
wherea
human
immunodefici
viru
hiv
sarscov
dramat
exampl
latter
air
travel
provid
mean
rapid
global
infecti
diseas
horror
social
disrupt
paralysi
travel
loss
economi
thu
caus
enorm
damag
mani
countri
addit
loss
human
live
therefor
standard
capabl
public
health
longer
nation
intern
issu
failur
public
health
surveil
lack
transpar
commun
critic
data
intern
commun
sever
critic
world
health
organ
graviti
damag
emerg
infecti
diseas
elev
issu
public
health
level
basic
valu
function
govern
democraci
human
right
nation
secur
economi
arbour
n
talbot
pj
